Aquestive Therapeutics, Inc. Common Stock
Symbol: AQST (NASDAQ)
4.97
▲ (1.76%) 0.086
Company Description:
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
Key Stats
- Today's Open: $4.88
- Today's High: $5.005
- Today's Low: $4.875
- Today's Volume: 295.42K
- Yesterday Close: $4.88
- Yesterday High: $5.03
- Yesterday Low: $4.87
- Yesterday Volume: 1.04M
- Last Min Volume: 850
- Last Min High: $4.975
- Last Min Low: $4.966
- Last Min VWAP: $4.97304
Company Profile
- Name: Aquestive Therapeutics, Inc. Common Stock
- Website: https://www.aquestive.com
- Listed Date: 2018-07-25
- Location: WARREN, NJ
- Market Status: Active
- CIK Number: 0001398733
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $590.35M
- Round Lot: 100
- Outstanding Shares: 120.97M
- Asset Type: CS
RECENT FILINGS FOR AQST
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-08 | 4 | View |
| 2025-09-08 | 4 | View |
| 2025-09-08 | 8-K | View |
| 2025-09-05 | 144 | View |
| 2025-09-04 | 144 | View |
| 2025-09-04 | 8-K | View |
| 2025-08-15 | 4 | View |
| 2025-08-15 | 8-K | View |
| 2025-08-14 | 424B5 | View |
| 2025-08-14 | 8-K | View |
| 2025-08-12 | 4 | View |
| 2025-08-11 | 10-Q | View |
| 2025-08-11 | 8-K | View |
| 2025-07-15 | 8-K | View |
| 2025-06-16 | 8-K | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
Latest News on AQST